Publication | Closed Access

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

Metastatic Breast CancerOncologyBreast OncologyPharmacologyPhase Ii StudyBreast CancerPharmacotherapyCancer TreatmentMedicine